Published in Proc Natl Acad Sci U S A on June 06, 2011
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature (2011) 6.21
Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell (2011) 4.65
Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell (2011) 3.62
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Generation of oligodendroglial cells by direct lineage conversion. Nat Biotechnol (2013) 2.64
In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol (2013) 2.56
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol (2013) 2.53
Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A (2013) 2.51
Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron (2013) 2.51
Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell (2011) 2.49
In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell (2013) 2.26
Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Cell Stem Cell (2011) 1.95
Induced neuronal cells: how to make and define a neuron. Cell Stem Cell (2011) 1.77
Molecular roadblocks for cellular reprogramming. Mol Cell (2012) 1.74
From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci U S A (2013) 1.71
Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat Commun (2013) 1.69
Lineage conversion methodologies meet the reprogramming toolbox. Nat Cell Biol (2012) 1.56
Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. Cell Stem Cell (2016) 1.54
Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. Nat Rev Mol Cell Biol (2013) 1.52
A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res (2013) 1.50
Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Reports (2014) 1.45
Mammalian-specific sequences in pou3f2 contribute to maternal behavior. Genome Biol Evol (2014) 1.44
Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci (2011) 1.40
Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum Mol Genet (2011) 1.37
Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity. Nat Neurosci (2013) 1.36
Generation of integration-free and region-specific neural progenitors from primate fibroblasts. Cell Rep (2013) 1.36
Maintaining differentiated cellular identity. Nat Rev Genet (2012) 1.32
Cell therapeutics in Parkinson's disease. Neurotherapeutics (2011) 1.32
Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res (2011) 1.26
Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell (2013) 1.25
Remote control of induced dopaminergic neurons in parkinsonian rats. J Clin Invest (2014) 1.23
Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc. Proc Natl Acad Sci U S A (2012) 1.22
Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One (2011) 1.21
Development-inspired reprogramming of the mammalian central nervous system. Science (2014) 1.21
Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol Ther Nucleic Acids (2012) 1.20
Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity. Genet Med (2014) 1.19
Immunogenicity of pluripotent stem cells and their derivatives. Circ Res (2013) 1.19
Induced regeneration--the progress and promise of direct reprogramming for heart repair. Nat Med (2013) 1.17
Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci (2012) 1.12
Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc Natl Acad Sci U S A (2015) 1.12
Environmental impact on direct neuronal reprogramming in vivo in the adult brain. Nat Commun (2013) 1.11
A predictive computational framework for direct reprogramming between human cell types. Nat Genet (2016) 1.10
Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation. Proc Natl Acad Sci U S A (2013) 1.09
Induction of fibroblasts to neurons through adenoviral gene delivery. Cell Res (2011) 1.08
The many roads to Rome: induction of neural precursor cells from fibroblasts. Curr Opin Genet Dev (2012) 1.08
Direct lineage reprogramming to neural cells. Curr Opin Neurobiol (2012) 1.08
Clinical application of stem cell therapy in Parkinson's disease. BMC Med (2012) 1.07
Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq. Nature (2016) 1.06
Isolation, characterization, and differentiation of progenitor cells from human adult adrenal medulla. Stem Cells Transl Med (2012) 1.05
"Seq-ing" insights into the epigenetics of neuronal gene regulation. Neuron (2013) 1.03
Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One (2012) 1.02
Direct conversion of human fibroblasts to induced serotonergic neurons. Mol Psychiatry (2015) 1.01
Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol Psychiatry (2014) 1.01
Direct conversion of fibroblasts into functional astrocytes by defined transcription factors. Stem Cell Reports (2014) 0.99
Towards translational therapies for multiple system atrophy. Prog Neurobiol (2014) 0.98
Cellular reprogramming: a small molecule perspective. Curr Opin Cell Biol (2012) 0.97
Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol (2015) 0.97
Generation of dopaminergic neurons directly from mouse fibroblasts and fibroblast-derived neural progenitors. Cell Res (2012) 0.96
Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors. Curr Mol Med (2012) 0.96
Generation of functional human serotonergic neurons from fibroblasts. Mol Psychiatry (2015) 0.96
Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr Opin Neurol (2012) 0.93
In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry. Cell Rep (2015) 0.93
Progress in the reprogramming of somatic cells. Circ Res (2013) 0.92
Pluripotent stem cells for the study of CNS development. Front Mol Neurosci (2011) 0.92
Cellular reprogramming: recent advances in modeling neurological diseases. J Neurosci (2011) 0.92
Neuronal transcription factors induce conversion of human glioma cells to neurons and inhibit tumorigenesis. PLoS One (2012) 0.91
Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion. Stem Cells (2014) 0.91
Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons. Nat Commun (2015) 0.90
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci (2016) 0.90
In vivo reprogramming for tissue repair. Nat Cell Biol (2015) 0.90
Selective conversion of fibroblasts into peripheral sensory neurons. Nat Neurosci (2014) 0.89
Direct induction of ramified microglia-like cells from human monocytes: dynamic microglial dysfunction in Nasu-Hakola disease. Sci Rep (2014) 0.89
Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts. J Stem Cells Regen Med (2012) 0.89
Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Acta Pharmacol Sin (2013) 0.89
Senescence impairs direct conversion of human somatic cells to neurons. Nat Commun (2014) 0.88
Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains. Brain Res (2012) 0.87
Activation of neural cell fate programs toward direct conversion of adult human fibroblasts into tri-potent neural progenitors using OCT-4. Stem Cells Dev (2014) 0.87
microRNA induced transdifferentiation. F1000 Biol Rep (2012) 0.86
Cationic, helical polypeptide-based gene delivery for IMR-90 fibroblasts and human embryonic stem cells. Biomater Sci (2013) 0.86
Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain. Sci Rep (2014) 0.86
Induced neuronal reprogramming. J Comp Neurol (2014) 0.85
The path from skin to brain: generation of functional neurons from fibroblasts. Mol Neurobiol (2012) 0.85
Induced neural stem cells (iNSCs) in neurodegenerative diseases. J Neural Transm (Vienna) (2013) 0.84
The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons. Acta Neuropathol (2013) 0.84
The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons. Biomaterials (2014) 0.84
Neuron-glia interaction as a possible glue to translate the mind-brain gap: a novel multi-dimensional approach toward psychology and psychiatry. Front Psychiatry (2013) 0.83
Cell-based therapy for neural disorders--anticipating challenges. Neurotherapeutics (2011) 0.83
Programming and reprogramming neuronal subtypes in the central nervous system. Dev Neurobiol (2012) 0.83
Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy. Stem Cells Int (2012) 0.83
Converted neural cells: induced to a cure? Protein Cell (2012) 0.83
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells. Nat Neurosci (2016) 0.83
Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish. Front Neurosci (2014) 0.82
Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Transl Med (2014) 0.82
Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. Nat Commun (2014) 0.82
Forward engineering neuronal diversity using direct reprogramming. EMBO J (2015) 0.82
iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls. Trends Mol Med (2013) 0.82
Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons. Front Cell Neurosci (2012) 0.82
The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology (2012) 0.82
MASH1/Ascl1a leads to GAP43 expression and axon regeneration in the adult CNS. PLoS One (2015) 0.81
Switching cell fate, ncRNAs coming to play. Cell Death Dis (2013) 0.81
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol (1997) 12.11
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol (2007) 5.36
Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature (2009) 3.70
Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci (1989) 3.66
Identification of intrinsic determinants of midbrain dopamine neurons. Cell (2006) 3.31
Cell behaviors and genetic lineages of the mesencephalon and rhombomere 1. Neuron (2004) 2.93
A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod (2003) 2.66
Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development (2007) 2.40
Forebrain and midbrain regions are deleted in Otx2-/- mutants due to a defective anterior neuroectoderm specification during gastrulation. Development (1995) 2.35
A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci (2000) 2.20
Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J Neurosci (2001) 1.99
Control of collagen production by human diploid lung fibroblasts. J Biol Chem (1980) 1.72
Tau EGFP embryonic stem cells: an efficient tool for neuronal lineage selection and transplantation. J Neurosci Res (2002) 1.71
Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum Gene Ther (2004) 1.27
Cooperation of Pax2 and Pax5 in midbrain and cerebellum development. Proc Natl Acad Sci U S A (1997) 1.16
Efficient reprogramming of adult neural stem cells to monocytes by ectopic expression of a single gene. Proc Natl Acad Sci U S A (2010) 1.04
Stem cell biologists sure play a mean pinball. Nat Biotechnol (2010) 0.94
Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A (2003) 5.09
KAP1 controls endogenous retroviruses in embryonic stem cells. Nature (2010) 4.02
In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol Cell (2011) 3.67
MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A (2008) 3.33
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proc Natl Acad Sci U S A (2013) 3.33
A draft genome of Yersinia pestis from victims of the Black Death. Nature (2011) 3.18
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci (2002) 3.12
Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis (2009) 2.99
Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells (2005) 2.88
Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci (2009) 2.74
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci (2008) 2.51
Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A (2013) 2.51
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain (2007) 2.49
Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron (2006) 2.38
Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature (2005) 2.33
Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep (2012) 2.31
Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis (2008) 2.26
Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol (2008) 2.17
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain (2005) 2.06
Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke (2007) 1.98
Cell therapy in Parkinson's disease. NeuroRx (2004) 1.93
Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.92
Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci (2006) 1.91
Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci (2009) 1.89
Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia (2009) 1.86
Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol (2003) 1.80
Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med (2010) 1.78
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci (2002) 1.74
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. Lancet Neurol (2013) 1.72
Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J Neurosci (2005) 1.67
Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci (2004) 1.61
The Kruppel-associated box repressor domain can trigger de novo promoter methylation during mouse early embryogenesis. J Biol Chem (2007) 1.59
Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci U S A (2009) 1.57
Strengths and limitations of the neurosphere culture system. Mol Neurobiol (2006) 1.56
Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55
L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis (2002) 1.54
Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci (2005) 1.51
Risk factors for tuberculosis. Pulm Med (2013) 1.48
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov Disord (2010) 1.47
Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts. Eur J Nucl Med Mol Imaging (2006) 1.46
Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron (2005) 1.44
MicroRNA-124 is a subventricular zone neuronal fate determinant. J Neurosci (2012) 1.43
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J Neurosci (2007) 1.42
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons. Proc Natl Acad Sci U S A (2012) 1.40
α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons. Sci Transl Med (2012) 1.40
Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest (2012) 1.40
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease. Brain (2011) 1.38
Stroke-induced neurogenesis in aged brain. Stroke (2005) 1.38
Neural stem and progenitor cells retain their potential for proliferation and differentiation into functional neurons despite lower number in aged brain. J Neurosci (2009) 1.37
Inflammation regulates functional integration of neurons born in adult brain. J Neurosci (2008) 1.35
Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells (2012) 1.34
Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol (2008) 1.33
Cell therapeutics in Parkinson's disease. Neurotherapeutics (2011) 1.32
Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res Dev Brain Res (2002) 1.32
Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol Aging (2005) 1.31
TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells. Genome Res (2012) 1.29
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest (2008) 1.29
MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain. Mol Cell Neurosci (2008) 1.29
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J (2013) 1.28
Neural grafting in Parkinson's disease Problems and possibilities. Prog Brain Res (2010) 1.28
Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum Gene Ther (2004) 1.27
West Nile virus infection of horses. Vet Res (2004) 1.26
Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab (2010) 1.24
Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol (2009) 1.23
Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J Neurosci (2004) 1.23
Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care (2003) 1.21
Data File Standard for Flow Cytometry, version FCS 3.1. Cytometry A (2010) 1.21
Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentiation with long-distance axonal projections. Exp Neurol (2002) 1.20
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain (2008) 1.19
Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke (2006) 1.18
Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS One (2012) 1.15
In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133. J Neurosci Res (2007) 1.15
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord (2011) 1.14
Efficient induction of functional neurons from adult human fibroblasts. Cell Cycle (2011) 1.12
Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther (2008) 1.12
Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine (2007) 1.12
Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur J Neurosci (2009) 1.11
Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11